跳至主要内容
临床试验/NCT04339179
NCT04339179已完成不适用

INA-RESPOND Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia

Ina-Respond19 个研究点 分布在 1 个国家目标入组 185 人开始时间: 2020年11月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ina-Respond
入组人数
185
试验地点
19
主要终点
Confirm Etiologies Among Suspected COVID-19 Cases

研究概览

简要总结

This observational study will investigate suspected infectious diseases of unknown etiology prospectively during outbreaks and at healthcare facilities, and retrospectively through historical samples where no etiology was ever determined. The study is designed to rapidly, flexibly, and consistently respond to any potential scenario in Indonesia, and the data collected will provide needed insight into the landscape of infectious diseases in the country. By better understanding the infectious causes of outbreaks and difficult hospitalized cases, the Indonesian Ministry of Health will be able to more accurately and efficiently control infectious diseases and craft healthcare policies.

详细描述

This is a study to identify the causative agents and describe the clinical characteristics of infectious disease outbreaks and difficult cases of unidentified etiology in Indonesia. It is a retrospective and prospective observational study with an exploratory design. There will be no intervention to the participants that is intended to affect their SoC or clinical outcome.

Retrospective study activities will be ongoing throughout the duration of the study. The INA-RESPOND Reference Lab will perform research tests on various specimens collected as part of historical outbreaks and previous difficult cases where an etiology was never identified.

Prospective study activities will be initiated upon official request from health authorities and health facilities/institutions. Requests are expected to be filtered through and evaluated by the 19 active INA-RESPOND Network sites before inclusion in the study. Samples collected during outbreaks and from difficult cases of unknown etiology will be analyzed at the INA-RESPOND Reference Lab at their own pace. Results from any research tests will be shared with the requesting authorities as research-use-only and are not intended to alter standard of care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Adult or child of any age hospitalized with a current episode of illness with a presumed infectious disease of unidentified etiology
  • Negative for Dengue virus infection by an antigen-based and antibody-based diagnostic test (i.e. NS1 antigen test and Dengue-specific IgM test)
  • Negative for Salmonella Typhi infection by Standard of Care testing (i.e. blood culture, Widal test, or Tubex rapid test)
  • Able to provide a documented informed consent
  • Agrees to the collection and storage of specimens for laboratory testing and/or future research (participants may decline storage of specimens for future research)
  • For Ongoing patients in outbreak situations: Referral from the MoH as part of a suspected or identified outbreak of infectious disease

排除标准

  • Investigators' discretion for patient safety and well being

结局指标

主要结局

Confirm Etiologies Among Suspected COVID-19 Cases

时间窗: at least 7-14 days after enrolment

Hospitalized suspected COVID-19 participants were monitored for at least 7-14 days after enrollment. Laboratory tests such as blood culture, RDT Influenza, RDT Dengue, Tubex TF, serology, and molecular were done to identify the etiology.

次要结局

未报告次要终点

研究者

发起方
Ina-Respond
申办方类型
Other
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验